Coave Therapeutics
Investment area
Seed Investments
Region
Europe
Date of investment
January 2025
Coave Therapeutics is a genetic medicine company pioneering the development of innovative solutions to enhance the precision, safety, efficacy and manufacturability of genetic medicines.